{"id":"https://openalex.org/W2085334308","doi":"https://doi.org/10.1002/pst.1583","title":"Investigation of the robustness of two models for assessing synergy in pre\u2010clinical drug combination studies","display_name":"Investigation of the robustness of two models for assessing synergy in pre\u2010clinical drug combination studies","publication_year":2013,"publication_date":"2013-07-30","ids":{"openalex":"https://openalex.org/W2085334308","doi":"https://doi.org/10.1002/pst.1583","mag":"2085334308","pmid":"https://pubmed.ncbi.nlm.nih.gov/23907796"},"language":"en","primary_location":{"id":"doi:10.1002/pst.1583","doi":"https://doi.org/10.1002/pst.1583","is_oa":false,"landing_page_url":"https://doi.org/10.1002/pst.1583","pdf_url":null,"source":{"id":"https://openalex.org/S141766756","display_name":"Pharmaceutical Statistics","issn_l":"1539-1604","issn":["1539-1604","1539-1612"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceutical Statistics","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Anne Whitehead","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I67415387","display_name":"Lancaster University","ror":"https://ror.org/04f2nsd36","country_code":"GB","type":"education","lineage":["https://openalex.org/I67415387"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Anne Whitehead","raw_affiliation_strings":["Medical and Pharmaceutical Statistics Research Unit, Department of Mathematics and Statistics , Lancaster University , Lancaster, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical and Pharmaceutical Statistics Research Unit, Department of Mathematics and Statistics , Lancaster University , Lancaster, UK","institution_ids":["https://openalex.org/I67415387"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025848685","display_name":"Ting\u2010Li Su","orcid":"https://orcid.org/0000-0003-3311-4998","observed_orcids":["https://orcid.org/0000-0003-3311-4998"]},"institutions":[{"id":"https://openalex.org/I67415387","display_name":"Lancaster University","ror":"https://ror.org/04f2nsd36","country_code":"GB","type":"education","lineage":["https://openalex.org/I67415387"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Ting\u2010Li Su","raw_affiliation_strings":["Medical and Pharmaceutical Statistics Research Unit, Department of Mathematics and Statistics , Lancaster University , Lancaster, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical and Pharmaceutical Statistics Research Unit, Department of Mathematics and Statistics , Lancaster University , Lancaster, UK","institution_ids":["https://openalex.org/I67415387"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042471100","display_name":"Helene Hoegsbro Thygesen","orcid":"https://orcid.org/0000-0003-0453-5144","observed_orcids":["https://orcid.org/0000-0003-0453-5144"]},"institutions":[{"id":"https://openalex.org/I2801331674","display_name":"St James's University Hospital","ror":"https://ror.org/013s89d74","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2799390153","https://openalex.org/I2801331674"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Helene Thygesen","raw_affiliation_strings":["Leeds Institute of Molecular Medicine St James's University Hospital Leeds UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Leeds Institute of Molecular Medicine St James's University Hospital Leeds UK","institution_ids":["https://openalex.org/I2801331674"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009872155","display_name":"Matthew Sperrin","orcid":"https://orcid.org/0000-0002-5351-9960","observed_orcids":["https://orcid.org/0000-0002-5351-9960"]},"institutions":[{"id":"https://openalex.org/I28407311","display_name":"University of Manchester","ror":"https://ror.org/027m9bs27","country_code":"GB","type":"education","lineage":["https://openalex.org/I28407311"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Matthew Sperrin","raw_affiliation_strings":["Centre for Health Informatics, Institute of Population Health, University of Manchester, Manchester, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Health Informatics, Institute of Population Health, University of Manchester, Manchester, UK","institution_ids":["https://openalex.org/I28407311"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5039588102","display_name":"Chris G. Harbron","orcid":"https://orcid.org/0000-0002-4353-5780","observed_orcids":["https://orcid.org/0000-0002-4353-5780"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Chris Harbron","raw_affiliation_strings":["Discovery Statistics AstraZeneca R&D Macclesfield UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Discovery Statistics AstraZeneca R&D Macclesfield UK","institution_ids":["https://openalex.org/I105036370"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I67415387"],"apc_list":{"value":4880,"currency":"USD","value_usd":4880},"apc_paid":null,"fwci":0.8398,"has_fulltext":false,"cited_by_count":6,"citation_normalized_percentile":{"value":0.80059985,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"12","issue":"5","first_page":"300","last_page":"308"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":0.9199000000953674,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":0.9199000000953674,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11798","display_name":"Optimal Experimental Design Methods","score":0.018300000578165054,"subfield":{"id":"https://openalex.org/subfields/1803","display_name":"Management Science and Operations Research"},"field":{"id":"https://openalex.org/fields/18","display_name":"Decision Sciences"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10243","display_name":"Statistical Methods and Bayesian Inference","score":0.011900000274181366,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/drug-synergy","display_name":"drug synergy","score":0.9039999842643738},{"id":"https://openalex.org/keywords/hill-equation","display_name":"Hill equation","score":0.7390000224113464},{"id":"https://openalex.org/keywords/cell-viability","display_name":"cell viability","score":0.6349999904632568},{"id":"https://openalex.org/keywords/dose-response-curves","display_name":"dose-response curves","score":0.4869999885559082},{"id":"https://openalex.org/keywords/heteroscedasticity","display_name":"heteroscedasticity","score":0.75},{"id":"https://openalex.org/keywords/confidence-interval-coverage","display_name":"confidence interval coverage","score":0.6499999761581421},{"id":"https://openalex.org/keywords/model-misspecification","display_name":"model misspecification","score":0.574999988079071},{"id":"https://openalex.org/keywords/cell-survival","display_name":"cell survival","score":0.3059999942779541}],"concepts":[{"id":"https://openalex.org/C104409967","wikidata":"https://www.wikidata.org/wiki/Q1054836","display_name":"Homoscedasticity","level":3,"score":0.8330763578414917},{"id":"https://openalex.org/C58315980","wikidata":"https://www.wikidata.org/wiki/Q179436","display_name":"Asymptote","level":2,"score":0.8320168256759644},{"id":"https://openalex.org/C101104100","wikidata":"https://www.wikidata.org/wiki/Q1063540","display_name":"Heteroscedasticity","level":2,"score":0.7252312898635864},{"id":"https://openalex.org/C63479239","wikidata":"https://www.wikidata.org/wiki/Q7353546","display_name":"Robustness (evolution)","level":3,"score":0.6530318260192871},{"id":"https://openalex.org/C105795698","wikidata":"https://www.wikidata.org/wiki/Q12483","display_name":"Statistics","level":1,"score":0.5326972007751465},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.49778079986572266},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.492601215839386},{"id":"https://openalex.org/C196083921","wikidata":"https://www.wikidata.org/wiki/Q7915758","display_name":"Variance (accounting)","level":2,"score":0.4418303370475769},{"id":"https://openalex.org/C149782125","wikidata":"https://www.wikidata.org/wiki/Q160039","display_name":"Econometrics","level":1,"score":0.38376376032829285},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.3242092728614807},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.16069722175598145},{"id":"https://openalex.org/C121955636","wikidata":"https://www.wikidata.org/wiki/Q4116214","display_name":"Accounting","level":1,"score":0.0},{"id":"https://openalex.org/C2524010","wikidata":"https://www.wikidata.org/wiki/Q8087","display_name":"Geometry","level":1,"score":0.0},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D004353","descriptor_name":"Drug Evaluation, Preclinical","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":true},{"descriptor_ui":"D004357","descriptor_name":"Drug Synergism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":true},{"descriptor_ui":"D008954","descriptor_name":"Models, Biological","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1002/pst.1583","doi":"https://doi.org/10.1002/pst.1583","is_oa":false,"landing_page_url":"https://doi.org/10.1002/pst.1583","pdf_url":null,"source":{"id":"https://openalex.org/S141766756","display_name":"Pharmaceutical Statistics","issn_l":"1539-1604","issn":["1539-1604","1539-1612"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceutical Statistics","raw_type":"journal-article"},{"id":"pmid:23907796","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23907796","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceutical statistics","raw_type":"Journal Article"},{"id":"pmh:oai:pure.atira.dk:openaire_cris_publications/866f13ee-5071-4a86-b7ad-16ab824504d8","doi":null,"is_oa":false,"landing_page_url":"https://research.manchester.ac.uk/en/publications/866f13ee-5071-4a86-b7ad-16ab824504d8","pdf_url":null,"source":{"id":"https://openalex.org/S4306400662","display_name":"Research Explorer (The University of Manchester)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I28407311","host_organization_name":"University of Manchester","host_organization_lineage":["https://openalex.org/I28407311"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Whitehead, A, Su, T-L, Thygesen, H, Sperrin, M & Harbron, C 2013, 'Investigation of the robustness of two models for assessing synergy in pre-clinical drug combination studies.', Pharmaceutical Statistics, vol. 12, no. 5, pp. 300-308. https://doi.org/10.1002/pst.1583","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.6240000128746033,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G3572308733","display_name":"MICA: Health e-Research Centre","funder_award_id":"MR/K006665/1","funder_id":"https://openalex.org/F4320334626","funder_display_name":"Medical Research Council"},{"id":"https://openalex.org/G5370460276","display_name":"Health e-Research Centre -HeRC","funder_award_id":"MC_PC_13042","funder_id":"https://openalex.org/F4320334626","funder_display_name":"Medical Research Council"}],"funders":[{"id":"https://openalex.org/F4320334626","display_name":"Medical Research Council","ror":"https://ror.org/03x94j517"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":11,"referenced_works":["https://openalex.org/W1538240916","https://openalex.org/W2024101513","https://openalex.org/W2045359273","https://openalex.org/W2060737851","https://openalex.org/W2077945404","https://openalex.org/W2087617431","https://openalex.org/W2120767637","https://openalex.org/W2151672555","https://openalex.org/W2320205132","https://openalex.org/W2329253854","https://openalex.org/W2586256972"],"related_works":["https://openalex.org/W2989954637","https://openalex.org/W3204895626","https://openalex.org/W7054527604","https://openalex.org/W2120767637","https://openalex.org/W2972783946","https://openalex.org/W1972699120","https://openalex.org/W3106336945","https://openalex.org/W2938160530","https://openalex.org/W6887822537","https://openalex.org/W2955759669"],"abstract_inverted_index":{"Pre-clinical":[0],"studies":[1],"may":[2,110],"be":[3,111,154,202,219],"used":[4,18,34],"to":[5,80,87,153,188,201,218],"screen":[6],"for":[7,19,65,120,177],"synergistic":[8],"combinations":[9],"of":[10,14,28,51,128,131,137,141,148,159,172,207],"drugs.":[11],"The":[12,83,204],"types":[13],"in":[15],"vitro":[16],"assays":[17],"this":[20,114],"purpose":[21],"will":[22],"depend":[23],"upon":[24],"the":[25,89,107,126,135,149,160,173,178,186,190],"disease":[26],"area":[27],"interest.":[29],"In":[30,113],"oncology,":[31],"one":[32],"frequently":[33],"study":[35],"measures":[36],"cell":[37,55,77],"line":[38],"viability:":[39],"cells":[40],"placed":[41],"into":[42],"wells":[43],"on":[44,134],"a":[45,103],"plate":[46],"are":[47,71,85,164],"treated":[48],"with":[49,92],"doses":[50],"two":[52,118],"compounds,":[53],"and":[54,74,94,99,185,209],"viability":[56],"is":[57],"assessed":[58],"from":[59,139],"an":[60,211],"optical":[61],"density":[62],"measurement":[63],"corrected":[64],"blank":[66],"well":[67],"values.":[68],"These":[69],"measurements":[70,168],"often":[72],"transformed":[73,183],"analysed":[75],"as":[76],"survival":[78],"relative":[79],"untreated":[81],"wells.":[82],"monotherapies":[84],"assumed":[86],"follow":[88],"Hill":[90],"equation":[91],"lower":[93],"upper":[95,191],"asymptotes":[96],"at":[97],"0":[98],"1,":[100],"respectively.":[101],"Additionally,":[102],"common":[104],"variance":[105],"about":[106],"dose-response":[108],"curve":[109],"assumed.":[112],"paper,":[115],"we":[116],"consider":[117],"models":[119,130],"incorporating":[121],"synergy":[122,138,150,179],"parameters.":[123],"We":[124,144],"investigate":[125],"effect":[127],"different":[129],"biological":[132],"variation":[133],"assessment":[136],"both":[140],"these":[142],"models.":[143],"show":[145],"that":[146],"estimates":[147,158],"parameters":[151,163,180],"appear":[152],"robust,":[155],"even":[156],"when":[157],"other":[161],"model":[162,214],"biased.":[165],"Using":[166],"untransformed":[167],"provides":[169],"better":[170],"coverage":[171],"95%":[174],"confidence":[175],"intervals":[176],"than":[181],"using":[182],"measurements,":[184],"requirement":[187],"fit":[189],"asymptote":[192],"does":[193,215],"not":[194,216],"cause":[195],"difficulties.":[196],"Assuming":[197],"homoscedastic":[198],"variances":[199],"appears":[200],"robust.":[203],"added":[205],"complexity":[206],"determining":[208],"fitting":[210],"appropriate":[212],"heteroscedastic":[213],"seem":[217],"justified.":[220]},"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":1}],"updated_date":"2026-11-03T10:50:19.383937","created_date":"2016-06-24T00:00:00"}